Plant Health Care (LON:PHC)‘s stock had its “buy” rating reaffirmed by stock analysts at Liberum Capital in a report issued on Tuesday, December 12th. They currently have a GBX 45 ($0.61) price target on the stock. Liberum Capital’s price objective suggests a potential upside of 183.46% from the stock’s previous close.
Shares of Plant Health Care (LON:PHC) opened at GBX 15.88 ($0.21) on Tuesday. Plant Health Care has a 12 month low of GBX 13 ($0.17) and a 12 month high of GBX 35 ($0.47). The firm has a market cap of $24.04 and a P/E ratio of -396.88.
COPYRIGHT VIOLATION NOTICE: “Plant Health Care (PHC) Rating Reiterated by Liberum Capital” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/25/plant-health-care-phc-rating-reiterated-by-liberum-capital.html.
Plant Health Care Company Profile
Plant Health Care plc provides agricultural biological products and technology solutions. The Company’s segments include Americas, Mexico, Rest of World and New Technology. The Company focuses on businesses, including New Technology and Commercial. Its Commercial business is focused on the sale of biological products.
Receive News & Ratings for Plant Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plant Health Care and related companies with MarketBeat.com's FREE daily email newsletter.